(Q38860367)

7 September 2017

title

Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells (English)

1 reference

7 September 2017

1 reference

Jungwhoi Lee

1

1 reference

7 September 2017

Song-I Han

series ordinal

2

1 reference

7 September 2017

Jeong-Hun Yun

series ordinal

3

1 reference

7 September 2017

Jae Hoon Kim

series ordinal

4

1 reference

7 September 2017

publication date

26 June 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

9385-9393

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3682-x

7 September 2017

exact match

0 references

cites work

Advanced pancreatic carcinoma: current treatment and future challenges

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Pancreatic cancer biology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Review of the biology of Quercetin and related bioflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Cancer chemoprevention with dietary phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

The flavonoid quercetin in disease prevention and therapy: facts and fancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Flavonoids and cancer prevention: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Quercetin and cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Multitargeted cancer prevention by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Epidermal growth factor receptor in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

The proto-oncogene c-src is involved in primordial follicle activation through the PI3K, PKC and MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Alterations in reproductive function in SRC tyrosine kinase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3682-X

Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma

21 January 2018

1 reference

12 December 2020

Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma

1 reference

12 December 2020

Dietary polyphenol quercetin targets pancreatic cancer stem cells

1 reference

12 December 2020

Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells

1 reference

12 December 2020

Biological activity of quercetin-3-O-glucoside, a known plant flavonoid

1 reference

12 December 2020

Molecular diagnosis of pancreatic cancer.

1 reference

12 December 2020

Cancer statistics, 2014

1 reference

12 December 2020

10.1007/S13277-015-3682-X

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1021570736

0 references

1 reference